PubMed · 11193885
Homocamptothecins: E-ring modified CPT analogues.
Abstract
Homocamptothecins (hCPT) are modified camptothecins (CPT) with a seven-membered beta-hydroxylactone instead of the naturally occurring six-membered alpha-hydroxylactone. This E-ring modification fully conserves the ability to stabilize topo I-DNA single-strand breaks and stimulates high levels of DNA cleavage. A key feature is the irreversibility of E-ring opening, which should give reduced toxicity. Substituted hCPTs have been selected for their high antiproliferative activity on a panel of tumor cell lines, including those with cross resistance, and were found to be active at very low doses in a variety of human tumor xenografts when administered orally. BN 80915, a difluoro-hCPT, has entered clinical trials.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
O Lavergne, D Demarquay, P G Kasprzyk, D C Bigg. 2000. Homocamptothecins: E-ring modified CPT analogues.. https://doi.org/10.1111/j.1749-6632.2000.tb07029.x
Cite the original work for its findings. Save a collection to share your selection of sources.